Food insecurity status is strongly linked to lower mental quality of life in individuals with multiple sclerosis, regardless of rural or urban residence.
Transdiagnostic interventions, such as the Unified Protocol, address both depression and anxiety and focus on the shared temperamental core of psychological disorders, which have been shown to impact functional outcomes as well.
Multiple sclerosis clinicians in Australia report that guideline application can improve standards of care but report varying practices in applying treatment guidelines.
More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.
Possible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.